| Issue Date | Title | Author(s) |
| Apr-2020 | Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors | Wang, Zhijie; Duan, Jianchun; Wang, Guoqiang; Zhao, Jing; Xu, Jiachen; Han, Jiefei; Zhao, Zhengyi; Zhao, Jun; Zhu, Bo; Zhuo, Minglei; Sun, Jianguo; Bai, Hua; Wan, Rui; Wang, Xin; Fei, Kailun; Wang, Shuhang; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Huang, Depei; Qi, Chuang; Gao, Chan; Bai, Yuezong; Dong, Hua; Xiong, Lei; Tian, Yanhua; Wang, Di; Xu, Chunwei; Wang, Wenxian; Li, Junling; Hu, Xingsheng; Cai, Shangli; Wang, Jie |
| 2019 | Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel | Wang, Zhijie; Duan, Jianchun; Cai, Shangli; Han, Miao; Dong, Hua; Zhao, Jun; Zhu, Bo; Wang, Shuhang; Zhuo, Minglei; Sun, Jianguo; Wang, Qiming; Bai, Hua; Han, Jiefei; Tian, Yanhua; Lu, Jing; Xu, Tongfu; Zhao, Xiaochen; Wang, Guoqiang; Cao, Xinkai; Li, Fugen; Wang, Dalei; Chen, Yuejun; Bai, Yuezong; Zhao, Jing; Zhao, Zhengyi; Zhang, Yuzi; Xiong, Lei; He, Jie; Gao, Shugeng; Wang, Jie |
| 2019 | Comprehensive immune transcriptomic subtypes of colorectal cancer for development of precision immunotherapy. | Jing, Zhou; Guo, Xueguang; Zhao, Jing; Zhao, Xiaochen; Zhang, Yuzi; Huang, Mengli; Cai, Shangli; Zhu, Haitao |
| Sep-2024 | Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG) | Jin, Yichen; Mu, Wei; Shi, Yezhen; Qi, Qingyi; Wang, Wenxiang; He, Yue; Sun, Xiaoran; Yang, Bo; Cui, Peng; Li, Chengcheng; Liu, Fang; Liu, Yuxia; Wang, Guoqiang; Zhao, Jing; Zhang, Yuzi; Zhang, Shuaitong; Cao, Caifang; Sun, Chao; Hong, Nan; Cai, Shangli; Tian, Jie; Yang, Fan; Chen, Kezhong |
| 20-May-2020 | Effect of MUC5B mutation on prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer. | Zheng, Hong; Duan, Wei; Zhao, Qun; Li, Chengcheng; Wang, Guoqiang; Zhang, Yuzi; Bai, Yuezong; Zhou, Yingchun |
| 1-Jun-2024 | Personalized tumor-informed circulating tumor DNA analysis in monitoring recurrence following resection of high-risk stage II-III gastrointestinal stromal tumor | Gao, Zhidong; Cheng, Baosen; Bao, Yudi; Cui, Peng; Du, Haiwei; Fan, Xuning; Peng, Di; Yang, Shuya; Wu, Xin; Zhao, Dongbing; Xing, Zhaodong; Cao, Feng; Zhang, Wei; Li, Bing; Li, Chengcheng; Zhang, Yuzi; Wang, Guoqiang; Cai, Shangli; Ye, Yingjiang |
| 2019 | Tumor mutation burden and immunogenicity in gastric cancer with HER2 alterations. | Wei, Bo; Xing, Xiaojing; Li, Ziyu; Han, Quanli; Hao, Yingxue; Zhou, Jing; Zhang, Yuzi; Zhao, Jing; Cai, Shangli; Gu, Yanhong; Chen, Tufeng |
| Mar-2020 | Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer A Systematic Review and Meta-analysis | Duan, Jianchun; Cui, Longgang; Zhao, Xiaochen; Bai, Hua; Cai, Shangli; Wang, Guoqiang; Zhao, Zhengyi; Zhao, Jing; Chen, Shiqing; Song, Jia; Qi, Chuang; Wang, Qing; Huang, Mengli; Zhang, Yuzi; Huang, Depei; Bai, Yuezong; Sun, Feng; Lee, J. Jack; Wang, Zhijie; Wang, Jie |
